Skip to main content

Table 4 Multivariate analysis for overall survival

From: Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer

In All Patients

 

No. of patients

No. of deaths

HR

95% CI

P

Performance status OMS

167

    

 0–1

134

91

1

  

  ≥ 2

33

30

2.191

1.413 to 3.396

0.0005

Stage

167

    

 Local/Loco-regional

84

48

1

  

 Advanced

83

73

2.558

1.722 to 3.802

<.0001

CD4+ T lymphocytes

167

    

  ≥ 500 /μl

120

80

1

  

  < 500 /μl

47

41

1.422

0.971 to 2.083

0.0704

In patients with local/loco-regional NSCLC

 

No. of patients

No. of deaths

HR

95% CI

P

Performance status OMS

84

    

 0–1

78

43

1

  

  ≥ 2

6

5

1.788

0.687 to 4.649

0.2335

CD4+ T lymphocytes

84

    

  ≥ 500 /μl

64

33

1

  

  < 500 /μl

20

15

2.028

1.065 to 3.817

0.0288

In Advanced NSCLC

 

No. of patients

No. of deaths

HR

95% CI

P

Performance status OMS

83

    

 0–1

56

48

1

  

  ≥ 2

27

25

2.270

1.354 to 3.806

0.0019

CD4+ T lymphocytes

83

    

  ≥ 500 /μl

56

47

1

  

  < 500 /μl

27

26

1.198

0.737 to 1.946

0.4668